Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI embryo selector tested in IVF study

NCT ID NCT07383480

Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested an artificial intelligence tool called EMA to see if it can rank embryos better than traditional methods for IVF. Researchers looked at data from 333 people who had IVF between 2022 and 2023. The goal was to see if the AI's scores matched up with expert embryologist assessments and could predict which embryos would lead to a pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
artificial intelligence-based embryo selection tool (EMA by AiVF)
What this could lead to
If successful, this AI tool could help doctors choose the best embryos for IVF, potentially increasing the chance of a successful pregnancy.
What could go wrong
This is a retrospective study, not a controlled trial, so it can't prove the AI directly improves outcomes. The AI may not work better than current methods in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

333 people

The number who actually took part.

Started

Jan 2022

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Couples, single women, or female couples undergoing assisted reproductive technology (ART) with IVF/ICSI techniques followed by blastocyst transfer.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * IVF or ICSI treatment between January 2022 and December 2023 * Fresh or frozen sperm from the partner or a donor * Embryo culture up to the 105th hour * Fresh or frozen embryo transfer on Day 5 * Known implantation data (clinical pregnancy assessed by the presence of cardiac activity at 6 weeks via ultrasound) Exclusion Criteria: * Epididymal or testicular sperm * Embryo culture with transfer on Day 2 or Day 3 * ICSI with oocyte donation or the use of thawed oocytes * Transfer of two embryos resulting in a singleton pregnancy * No blastocyst obtained on Day 5

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Helping Behavior infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence Couples or single women undergoing assisted reproductive technology (ART) with ivf/icsi techniques followed by blastocyst transfer Embryo transfer Reproductive techniques, assisted

Contacts and locations

Locations

  • CHU de Clermont-Ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.